114 related articles for article (PubMed ID: 22678675)
1. [Characteristics of the pharmacological treatment of toxic liver damage in patients with an alcohol abused syndrome and an acute severe ethanol poison].
Shilov VV; Shikalova IA; Vasil'ev SA; Loladze AT; Batotsyrenov BV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):45-8. PubMed ID: 22678675
[TBL] [Abstract][Full Text] [Related]
2. [Peculiarities of pharmacological correction of acute toxic hepatopathies in patients with severe forms of acute alcohol intoxication].
Shikalova IA; Shilov VV; Batots'orenov BV; Vasil'ev SA; Loladze AT
Klin Med (Mosk); 2012; 90(1):60-4. PubMed ID: 22567943
[TBL] [Abstract][Full Text] [Related]
3. [Comparative evaluation of clinical efficacy of drugs remaxol and ademetionine in patients with acute ethanol poisoning complicated by the toxic damage of the liver].
Shilov VV; Shikalova IA; Batotsyrenov BV; Andrianov AIu; Vasil'ev SA; Loladze AT
Georgian Med News; 2012 Apr; (205):38-43. PubMed ID: 22665730
[TBL] [Abstract][Full Text] [Related]
4. [Pecularities of correction of alcohol affctions of liver in patients with acute ethanol poisoning in the setting of consequence of toxic effect of ethanol].
Shilov VV; batotsyrenov BV; Vasil'ev SA; Shikalova IA; Kuznetsov OA
Voen Med Zh; 2012 Jun; 333(6):38-41. PubMed ID: 22888700
[TBL] [Abstract][Full Text] [Related]
5. [Correction of metabolic disorders during treatment of alcohol-induced liver injuries in patients with acute alcoholic intoxication].
Shilov VV; Shikalova IA; Vasil'ev SA; Batotsyrenov BV; Andrianov AIu
Klin Med (Mosk); 2013; 91(2):45-8. PubMed ID: 23718065
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological correction of toxic liver damage in patients with heavy forms of acute ethanol intoxication].
Shikalova IA; Shilov VV; Vasil'ev SA; Batotsyrenov BV; Loladze AT
Eksp Klin Farmakol; 2012; 75(4):30-3. PubMed ID: 22702109
[TBL] [Abstract][Full Text] [Related]
7. [Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage].
Bokhan NA; Abolonin AF; Ankudinova IÉ; Kurgak DI; Mandel' AI
Ter Arkh; 2012; 84(10):51-5. PubMed ID: 23227501
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of remaxol addition in the treatment of alcohol withdrawal syndrome].
Vinnikova MA; Utkin SI; Nenasteva AY; Zakharov MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):40-46. PubMed ID: 26977624
[TBL] [Abstract][Full Text] [Related]
9. [EXPERIENCE IN USE OF HEPATOPROTECTOR REMAXOL FOR TREATING LIVER CIRRHOSIS].
Gridchik IE; Kurdyakov AV; Matveev AI
Eksp Klin Farmakol; 2015; 78(12):11-4. PubMed ID: 27051921
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury].
Sukhanov DS
Ter Arkh; 2012; 84(11):26-9. PubMed ID: 23252243
[TBL] [Abstract][Full Text] [Related]
11. Alcohol and nutrition: caloric value, bioenergetics, and relationship to liver damage.
Mitchell MC; Herlong HF
Annu Rev Nutr; 1986; 6():457-74. PubMed ID: 3015171
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of ademetionine "Heptor" in the therapy of alcohol-dependent liver disease].
Tkachenko EI; Uspenskiĭ IuP; Skvortsova TE
Eksp Klin Gastroenterol; 2008; (2):106-12. PubMed ID: 19145875
[No Abstract] [Full Text] [Related]
13. [[Features of Pharmacological Correction of Alcoholic Fatty Liver Disease in Patients with Acute Ethanol Intoxication].].
Livanov GA; Shikalova IA; Lodyagin AN; Glushkov S; Batotsyrenov BV; Loladze AT; Kovalenko AL
Eksp Klin Gastroenterol; 2016; (5):45-50. PubMed ID: 28614644
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of hepatotropic agent Remaxol in oncological patients with postoperative liver dysfunction].
Karelov AE; Pyshnaia IV; Mitrokhina MV; Popel' IV; Gorokhov LV; Kremzel' EG; Naperov EV; Nikolaev AA
Eksp Klin Farmakol; 2013; 76(7):19-23. PubMed ID: 24006611
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years.
Lieber CS
Rocz Akad Med Bialymst; 2005; 50():7-20. PubMed ID: 16363067
[TBL] [Abstract][Full Text] [Related]
16. [AGE-SPECIFIC METABOLIC THERAPY FOR ALCOHOL DEPENDENCE IN ELDERLY PATIENTS WITH REGARD TO THEIR AKMEOLOGICAL FEATURES].
Zaplutanov VA; Spikina AA; Belov VG; Parfyonov UA; Ermishin YV
Adv Gerontol; 2015; 28(2):374-80. PubMed ID: 26856103
[TBL] [Abstract][Full Text] [Related]
17. [Alcoholic liver disease].
Waluga M; Hartleb M
Wiad Lek; 2003; 56(1-2):61-70. PubMed ID: 12901271
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenetic therapy of alcoholic liver disease].
Volchkova EV
Eksp Klin Gastroenterol; 2002; (5):77-8, 129. PubMed ID: 12619584
[TBL] [Abstract][Full Text] [Related]
19. [Essential phospholipids in the treatment of alcohol-related liver disease: clinical and experimental study].
Butov MA; Vasilevskaia AS; Maslova OA; Mnikhovich MB
Eksp Klin Gastroenterol; 2014; (10):28-32. PubMed ID: 25911927
[TBL] [Abstract][Full Text] [Related]
20. [Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
Diaz Belmont A; Dominguez Henkel R; Uribe Ancira F
An Med Interna; 1996 Jan; 13(1):9-15. PubMed ID: 8679834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
